See also Non-steroidal anti-inflammatory drugs (NSAIDs)

General information

Fenclofenac was withdrawn in the UK after its licence was not renewed because of its adverse drug reactions profile [ ]. Data from the UK's Committee on Safety of Medicines included records of seven deaths and 895 adverse reactions in patients taking fenclofenac. Shortly afterwards it was withdrawn in all other countries in which it had been marketed.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here